(Q79275806)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14608535%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

title

Expression of CEA, Tag-72, and Lewis-Y antigen in primary and metastatic lesions of ovarian carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14608535%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference

10

William E Grizzle

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14608535%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

author name string

Cristina Rodriguez-Burford

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14608535%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Helena Sviglin

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14608535%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

David C. Chhieng

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14608535

30 March 2024

Lynya I. Talley

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14608535

30 March 2024

Cecil R. Stockard

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14608535

30 March 2024

Marc J. Kleinberg

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14608535

30 March 2024

Mack N. Barnes

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14608535

30 March 2024

Edward E. Partridge

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14608535

30 March 2024

M. B. Khazaeli

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14608535

30 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14608535

30 March 2024

publication date

1 October 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14608535%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

20 December 2019

https://api.elsevier.com/content/article/PII:S0046817703003551?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1053/S0046-8177(03)00355-1

https://api.elsevier.com/content/article/PII:S0046817703003551?httpAccept=text/plain

30 March 2024

1 reference

https://api.crossref.org/works/10.1053/S0046-8177(03)00355-1

30 March 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14608535%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

volume

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14608535%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14608535%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

page(s)

1016-1021

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14608535%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

cites work

Ovarian cancer biology

2

1 reference

https://api.crossref.org/works/10.1053/S0046-8177(03)00355-1

Future directions for the management of ovarian cancer

30 March 2024

3

1 reference

https://api.crossref.org/works/10.1053/S0046-8177(03)00355-1

Antibody-guided irradiation of hepatic metastases using intrahepatically administered radiolabelled anti-CEA antibodies with simultaneous and reversible hepatic blood flow stasis using biodegradable starch microspheres.

30 March 2024

4

1 reference

https://api.crossref.org/works/10.1053/S0046-8177(03)00355-1

Intraperitoneal radioimmunotherapy of ovarian cancer with 177Lu-CC49: a phase I/II study

30 March 2024

5

1 reference

https://api.crossref.org/works/10.1053/S0046-8177(03)00355-1

Phase II study of dual 131I-labeled monoclonal antibody therapy with interferon in patients with metastatic colorectal cancer

30 March 2024

7

1 reference

https://api.crossref.org/works/10.1053/S0046-8177(03)00355-1

Radioimmunodiagnosis and therapy

30 March 2024

9

1 reference

https://api.crossref.org/works/10.1053/S0046-8177(03)00355-1

Monoclonal antibodies in the treatment of malignancy: basic concepts and recent developments

30 March 2024

12

1 reference

https://api.crossref.org/works/10.1053/S0046-8177(03)00355-1

Complementation of intracavitary and intravenous administration of a monoclonal antibody (B72.3) in patients with carcinoma

30 March 2024

15

1 reference

https://api.crossref.org/works/10.1053/S0046-8177(03)00355-1

Prognostic significance of Bcl-2 expression and p53 nuclear accumulation in colorectal adenocarcinoma

30 March 2024

19

1 reference

https://api.crossref.org/works/10.1053/S0046-8177(03)00355-1

The use of biomarker expression to characterize neoplastic processes

30 March 2024

20

1 reference

https://api.crossref.org/works/10.1053/S0046-8177(03)00355-1

Ep-Cam levels in prostatic adenocarcinoma and prostatic intraepithelial neoplasia

30 March 2024

21

1 reference

https://api.crossref.org/works/10.1053/S0046-8177(03)00355-1

Quantitation of cytosine deaminase mRNA by real-time reverse transcription polymerase chain reaction: a sensitive method for assessing 5-fluorocytosine toxicity in vitro

30 March 2024

22

1 reference

https://api.crossref.org/works/10.1053/S0046-8177(03)00355-1

Heterogeneity of antigen expression in advanced epithelial ovarian cancer

30 March 2024

23

1 reference

https://api.crossref.org/works/10.1053/S0046-8177(03)00355-1

Analysis of antigen expression at multiple tumor sites in epithelial ovarian cancer

30 March 2024

24

1 reference

https://api.crossref.org/works/10.1053/S0046-8177(03)00355-1

Flow cytometric DNA ploidy and S-phase heterogeneity in advanced ovarian carcinoma

30 March 2024

26

1 reference

https://api.crossref.org/works/10.1053/S0046-8177(03)00355-1

Flow cytometric analysis of lymph node metastases in advanced ovarian cancer: Clinical and biologic significance

30 March 2024

27

1 reference

https://api.crossref.org/works/10.1053/S0046-8177(03)00355-1

Immunophenotype of ovarian cancer as predictor of clinical outcome: evaluation at primary surgery and second-look procedure

30 March 2024

28

1 reference

https://api.crossref.org/works/10.1053/S0046-8177(03)00355-1

Comparison of p53, Ki-67, and CD44v6 expression between primary and matched metastatic lesions in ovarian cancer

30 March 2024

29

1 reference

https://api.crossref.org/works/10.1053/S0046-8177(03)00355-1

Biomarker conservation in primary and metastatic epithelial ovarian cancer

30 March 2024

30

1 reference

https://api.crossref.org/works/10.1053/S0046-8177(03)00355-1

Ovarian carcinoma heterogeneity as demonstrated by DNA ploidy

30 March 2024

31

1 reference

https://api.crossref.org/works/10.1053/S0046-8177(03)00355-1

30 March 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14608535%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference